14 March 2021 - People with advanced cancer who have run out of treatment options are missing out on cutting-edge genomic testing, or being forced into financial ruin to fund it themselves. Now there is a proposal that offers hope and will save lives.

While a funded trial is under way at the Garvan Institute, patients like Alison Day, 52, have to pay $10,000 for the molecular testing to find out what medications may buy them more time.

Read Daily Telegraph article